Investigators are sounding a new warning about NSAIDs and acute kidney injury in children.
Severe acute kidney injuries have been rising rapidly in the United States over the past 10 years.
The incidence of AKI requiring dialysis is now higher than the incidence of ESRD requiring dialysis or transplant.
Absence of a link found in a pooled analysis of two trials with a total of about 8,600 participants.
Hospitalizations for acute kidney injury rose along with increased use of ACE inhibitors and angiotensin receptor antagonists.
ACE inhibitor plus ARB failed to slow disease progression but increased acute kidney injury risk.
The antibiotic inhibits an enzyme that metabolizes calcium-channel blockers, raising levels of these drugs.
Patients whose statins were held in the 24 hours before cardiac surgery had higher levels of kidney injury biomarkers.
After adjusting for health insurance and income, African Americans no longer had a significantly elevated risk than Caucasians.
Infants aged one month or younger who experience acute kidney injury during hospitalization have a 31% death rate.
A prospective cohort study has shown plasma NGAL to be an accurate biomarker for predicting acute kidney injury.
A noninvasive, nonpharmacologic, ultrasound-based method of preventing renal ischemia-reperfusion injury could help prevent surgery-related AKI.
It might decrease the likelihood of renal function decline, however.
Nephrology consultations more than 48 after the day of acute kidney injury diagnosis are associated with greater mortality and dialysis dependence risk.
Prospective randomized study finds no difference in in-hospital mortality and dialysis dependence at three months compared with usual-start dialysis.
Dialysis dependence found to be less likely with continuous rather than intermittent renal replacement therapy.
Acute kidney injury was most likely to develop in men receiving combined androgen blockade.
Oral fluoroquinolones are associated with a small but significantly increased risk of acute kidney injury (AKI).